Munafa Stock Market Course + Intraday & FNO calls 
Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Array Biopharma (ARRY)
Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 11 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma
Array Biopharma Opened at 5.37 and Closed at: 5.35, which is 0.56% of previous session's close. It moved within a range of 5.28 and 5.53
The session was a Bearish session with an average volume of 4444100, which is -26.66% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 5.19 and resistance for tomorrow is 5.44
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 5.24, 5.14 resistance for tomorrow's hourly charts is 5.49, 5.64
10 Day SMA for Array Biopharma (ARRY) is 5.39 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Array Biopharma (ARRY) is 5.55 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Array Biopharma (ARRY) is 6.69 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 7.29 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Array Biopharma is 8.19 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Array Biopharma is at 5.55 and 200 DMA is at 8.19, while 50 DMA and 100 DMA are at 6.69 and 7.29 respectively
Array Biopharma (ARRY) moving average of 20 SMA is at 5.55 and 20 EMA is at 5.67
| Date | Closing Price | 20 SMA | 20 EMA |
| 11 Tue Aug | 5.35 | 5.55 | 5.67 |
| 10 Mon Aug | 5.32 | 5.6 | 5.7 |
| 07 Fri Aug | 5.55 | 5.65 | 5.74 |
| 06 Thu Aug | 5.23 | 5.67 | 5.76 |
| 05 Wed Aug | 5.64 | 5.73 | 5.82 |
| 04 Tue Aug | 6.00 | 5.77 | 5.84 |
Array Biopharma (ARRY) moving average of 50 SMA is at 6.69 and 50 EMA is at 6.44
| Date | Closing Price | 50 SMA | 50 EMA |
| 11 Tue Aug | 5.35 | 6.69 | 6.44 |
| 10 Mon Aug | 5.32 | 6.76 | 6.48 |
| 07 Fri Aug | 5.55 | 6.83 | 6.53 |
| 06 Thu Aug | 5.23 | 6.91 | 6.57 |
| 05 Wed Aug | 5.64 | 6.98 | 6.62 |
| 04 Tue Aug | 6.00 | 7.04 | 6.66 |
Array Biopharma (ARRY) moving average of 100 SMA is at 7.29 and 100 EMA is at 7.13
| Date | Closing Price | 100 SMA | 100 EMA |
| 11 Tue Aug | 5.35 | 7.29 | 7.13 |
| 10 Mon Aug | 5.32 | 7.31 | 7.17 |
| 07 Fri Aug | 5.55 | 7.32 | 7.21 |
| 06 Thu Aug | 5.23 | 7.34 | 7.24 |
| 05 Wed Aug | 5.64 | 7.35 | 7.28 |
| 04 Tue Aug | 6.00 | 7.37 | 7.31 |
Array Biopharma (ARRY) moving average of 200 SMA is at 8.19 and 200 EMA is at 7.53
| Date | Closing Price | 200 SMA | 200 EMA |
| 11 Tue Aug | 5.35 | 8.19 | 7.53 |
| 10 Mon Aug | 5.32 | 8.2 | 7.55 |
| 07 Fri Aug | 5.55 | 8.22 | 7.57 |
| 06 Thu Aug | 5.23 | 8.24 | 7.59 |
| 05 Wed Aug | 5.64 | 8.26 | 7.61 |
| 04 Tue Aug | 6.00 | 8.27 | 7.63 |
Smith Nephew has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Smith Nephew, about 9.94% more returns!
Glaxosmithkline Plc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 10.86% more returns!
Cigna Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Cigna Corporation, about 11.03% more returns!
Baxter International has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Baxter International, about 32.59% more returns!
Sensus Healthcare has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Sensus Healthcare, about 17.05% more returns!
Sol Gel has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Sol Gel, about 14.2% more returns!
Scynexis Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Scynexis Inc, about 22.44% more returns!
Pulmatrix Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 13.78% more returns!
Array Biopharma has performed better than Organogenesis Holdings in short term. Holding Array Biopharma could be a better choice for now!
Medicinova Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Medicinova Inc, about 7.36% more returns!
Microbot Medical has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Microbot Medical, about 8.25% more returns!
Lipocine Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Lipocine Inc, about 5.67% more returns!
Kura Oncology has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Kura Oncology, about 5.58% more returns!
Inmune Bio has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Inmune Bio, about 14.4% more returns!
Geron Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Geron Corporation, about 29.19% more returns!
Array Biopharma has performed better than Fortress Biotech in short term. Holding Array Biopharma could be a better choice for now!
Editas Medicine has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Editas Medicine, about 16.83% more returns!
Array Biopharma has performed better than Ardelyx Inc in short term. Holding Array Biopharma could be a better choice for now!
Aceto Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Aceto Corporation, about 14.4% more returns!
Array Biopharma Technical analysis of indicators
Price action analysis of Array Biopharma (ARRY) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.43 and Array Biopharma ARRY stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARRY Experts View which covers a lot of information including buying and selling signals
ARRY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
